Primedica Corporation

Primedica Corporation is an international contract research organization (CRO) leader, delivering nonclinical development services in partnership with pharmaceutical, biotechnology, and medical device companies in an effort to meet their product development needs. Primedica's more than 500 employees play a critical role in the commercial development of human therapeutics, from discovery support and toxicologic assessments to manufacturing and release testing of marketed products.

Focused on customer service, scientific leadership, and regulatory expertise, Primedica serves as a flexible, efficient, and cost-effective extension of our clients' own internal development activities. This relationship helps to move new therapeutics from discovery to market as quickly and safely as possible.

Primedica Corporation is a wholly owned subsidiary of Genzyme Transgenics Corporation.